Citanest Forte Dental Injection, Solution
NDC Package 51004-5801-6

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Citanest Forte Dental (prilocaine hcl and epinephrine) injection is citanest Forte is indicated for the production of local anesthesia in dentistry by nerve block or infiltration techniques. This formulation utilizes a injection, solution delivery system. Marketed by Novocol Pharmaceutical Of Canada, Inc., this product is identified by NDC 51004-5801 and is authorized under FDA application ANDA078959.

Identification & Billing

NDC Package Code
51004-5801-6
Package Description
50 CARTRIDGE in 1 CARTON / 1.8 mL in 1 CARTRIDGE
Product Code
51004-5801
11-Digit Billing Format
51004580106
RxNorm Crosswalk
  • RxCUI: 1596950 - prilocaine HCl 4 % / EPINEPHrine 1:200,000 in 1.8 ML Cartridge
  • RxCUI: 1596950 - 1.8 ML epinephrine 0.005 MG/ML / prilocaine hydrochloride 40 MG/ML Cartridge
  • RxCUI: 1596950 - epinephrine 1:200,000 / prilocaine HCl 4 % 1.8 ML Cartridge
  • RxCUI: 1596950 - prilocaine HCl 4 % / epinephrine (as epinephrine bitartrate) 1:200,000 in 1.8 ML Cartridge
  • RxCUI: 1993224 - Citanest Forte 4 % / 1:200,000 in 1.8 ML Cartridge

Clinical Specifications

Proprietary Name
Citanest Forte Dental
Non-Proprietary Name
Prilocaine Hcl And Epinephrine
Substance Name
Epinephrine Bitartrate; Prilocaine Hydrochloride
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Submucosal - Administration beneath the mucous membrane.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Citanest Forte is indicated for the production of local anesthesia in dentistry by nerve block or infiltration techniques. Only accepted procedures for these techniques as described in standard textbooks are recommended.

Regulatory & Marketing

Labeler Name
Novocol Pharmaceutical Of Canada, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA078959
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-04-2017
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51004-5801-6 identifies a specific commercial package of 50 cartridge in 1 carton / 1.8 ml in 1 cartridge of Citanest Forte Dental, a human prescription drug labeled by Novocol Pharmaceutical Of Canada, Inc.. This injection, solution is formulated for submucosal use and contains epinephrine bitartrate; prilocaine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Novocol Pharmaceutical Of Canada, Inc. on December 04, 2017. The current certification is valid through December 31, 2027.

How is this Novocol Pharmaceutical Of Canada, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51004580106. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
51004-5801-6
11-Digit CMS (5-4-2)
51004-5801-06

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.